Trajectories of disease-modifying therapies and associated sickness absence and disability pension among people with multiple sclerosis

被引：0
|
作者：
Teni, F. S. [1 ]
Machado, A. [1 ]
Murley, C. [1 ]
He, A. [2 ]
Fink, K. [2 ]
Gyllensten, H. [3 ]
Glaser, A. [2 ]
Alexanderson, K. [1 ]
Hillert, J. [2 ]
Friberg, E. [1 ]
机构：
[1] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden
[3] Univ Gothenburg, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
基金：
瑞典研究理事会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P770
引用
收藏
页码：672 / 673
页数：2
相关论文
共 50 条
  • [41] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [42] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
  • [43] Impact of adherence to disease-modifying therapies on employment among veterans with multiple sclerosis
    Rabadi, Meheroz H.
    Just, Kimberly
    Xu, Chao
    DISABILITY AND REHABILITATION, 2022, 44 (16) : 4415 - 4420
  • [44] Sickness absence and disability pension within different employment status in multiple sclerosis
    Machado, A.
    Murley, C.
    Hillert, J.
    Alexanderson, K.
    Friberg, E.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 459 - 459
  • [45] Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies
    Murley, Chantelle
    Pettersson, Emma
    Hillert, Jan
    Machado, Alejandra
    Friberg, Emilie
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
  • [46] Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies
    Ronen Spierer
    Idit Lavi
    Sivan Bloch
    Marianna Mazar
    Daniel Golan
    Journal of Neurology, 2023, 270 : 4632 - 4639
  • [47] Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies
    Spierer, Ronen
    Lavi, Idit
    Bloch, Sivan
    Mazar, Marianna
    Golan, Daniel
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4632 - 4639
  • [48] Disease-modifying therapies in multiple sclerosis: A focused review of rituximab
    Alping, Peter
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (05) : 550 - 564
  • [49] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [50] The emergence of follow-on disease-modifying therapies for multiple sclerosis
    Moss, Brandon P.
    Cohen, Jeffrey A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (12) : 1560 - 1565
12345